ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 10/07/2024 at 22:01, 1 year 8 months ago

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
Abivax congratulates Victor Ambros and Gary Ruvkun on their Nobel Prize for the discovery of microRNA and its role in post-transcriptional gene regulation

Abivax MicroRNA Nobel Prize Victor Ambros Gary Ruvkun
PRESS RELEASE

published on 10/07/2024 at 22:01, 1 year 8 months ago

Abivax félicite Victor Ambros et Gary Ruvkun pour leur prix Nobel, récompensant leur découverte du microARN et son rôle dans la régulation post transcriptionnelle des gènes
Abivax félicite Victor Ambros et Gary Ruvkun pour leur prix Nobel concernant la découverte du microARN et sa régulation post-transcriptionnelle des gènes. Réactions et objectifs d'Abivax pour l'avenir

Abivax Rectocolite Hémorragique MicroARN Prix Nobel Innovation Thérapeutique
BRIEF

published on 10/03/2024 at 22:06, 1 year 8 months ago

Abivax recrute un premier patient pour son essai clinique sur la maladie de Crohn

Biotechnologie Abivax Obefazimod Maladie De Crohn Essai Clinique
BRIEF

published on 10/03/2024 at 22:06, 1 year 8 months ago

Abivax recruits first patient for its clinical trial on Crohn's disease

Biotechnology Abivax Obefazimod Clinical Trial Crohn's Disease
PRESS RELEASE

published on 10/03/2024 at 22:01, 1 year 8 months ago

Abivax annonce le recrutement d'un premier patient dans Enhance-CD, l'essai clinique de phase 2b avec obefazimod dans la maladie de Crohn
Abivax annonce le recrutement du premier patient dans Enhance-CD, l'essai clinique de phase 2b avec obefazimod dans la maladie de Crohn

Abivax Obefazimod Maladie De Crohn Phase 2b Essai Clinique
PRESS RELEASE

published on 10/03/2024 at 22:01, 1 year 8 months ago

Abivax annonce le recrutement d'un premier patient dans Enhance-CD, l'essai clinique de phase 2b avec obefazimod dans la maladie de Crohn
Abivax recrute premier patient pour Enhance-CD, essai clinique phase 2b obefazimod maladie Crohn. Etude 3 phases. Obefazimod, traitement prometteur

Abivax Obefazimod Maladie De Crohn Essai Clinique Enhance-CD
PRESS RELEASE

published on 10/03/2024 at 22:01, 1 year 8 months ago

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
Abivax announces enrollment of first patient in Phase 2b trial of Obefazimod for Crohn's Disease, aiming for convenient, effective treatment option with fewer daily burdens

Abivax Obefazimod Phase 2B Trial Immune Response Crohn's Disease
BRIEF

published on 10/03/2024 at 08:35, 1 year 8 months ago

Abivax Announces Positive Results for Obefazimod in Ulcerative Colitis Treatment

Abivax Obefazimod Ulcerative Colitis Clinical Study Safety Analysis
BRIEF

published on 10/03/2024 at 08:35, 1 year 8 months ago

Abivax annonce des résultats positifs pour l'obéfazimod dans le traitement de la rectocolite hémorragique

Abivax Obefazimod Rectocolite Hémorragique Étude Clinique Analyse De Sécurité
PRESS RELEASE

published on 10/03/2024 at 08:30, 1 year 8 months ago

Résultats positifs d'une analyse intermédiaire portant sur l'efficacité et la tolérance d’obefazimod 25 mg chez des patients atteints de RCH modérée à sévère après deux ans de maintenance en ouvert
Abivax annonce des résultats positifs pour obefazimod 25 mg chez les patients atteints de RCH modérée à sévère après 2 ans de maintenance. Analyse intermédiaire d'une étude de 6 ans

Abivax Obefazimod Efficacité RCH Rémission Clinique

Published on 06/22/2026 at 19:45, 47 minutes ago

Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 4 hours 34 minutes ago

Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 5 hours 2 minutes ago

NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 5 hours 32 minutes ago

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 6 hours 31 minutes ago

Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate

View all ACCESSWIRE

Published on 06/22/2026 at 19:27, 1 hour 4 minutes ago

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 1 hour 37 minutes ago

EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:30, 2 hours 1 minute ago

Amprion welcomes RWE’s entry into M31
Published on 06/22/2026 at 18:30, 2 hours 1 minute ago

Avolta awarded 10-year contract at Orlando International Airport across travel retail and F&B
Published on 06/22/2026 at 18:05, 2 hours 26 minutes ago

Bybit EU Strengthens European Positioning Ahead of MiCAR Transition

View all EQS

Published on 06/22/2026 at 18:45, 1 hour 47 minutes ago

Governance evolution
Published on 06/22/2026 at 18:45, 1 hour 47 minutes ago

ÉVOLUTION DE LA GOUVERNANCE
Published on 06/22/2026 at 18:16, 2 hours 15 minutes ago

ANTOINE FREY INCREASES HIS STAKE IN FREY
Published on 06/22/2026 at 18:16, 2 hours 15 minutes ago

ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 2 hours 32 minutes ago

GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION

View all LES ECHOS COMFI WIRE

News